GLP-1 receptor agonists and HBA1c target of

K. Esposito, C. Mosca, C. Brancario, P. Chiodini, A. Ceriello, D. Giugliano

Research output: Contribution to journalArticlepeer-review


Objective: Glucagon-like peptide-1 (GLP-1) receptor agonists are available for the treatment of type 2 diabetes. We assessed the efficacy of exenatide and liraglutide to reach the HbA1c target of 2 value=0.513, p

Original languageEnglish
Pages (from-to)1519-1528
Number of pages10
JournalCurrent Medical Research and Opinion
Issue number8
Publication statusPublished - Aug 2011


  • Clinical trials
  • Exenatide
  • GLP-1 analogues
  • HbA1c <7%
  • Liraglutide
  • Type 2 diabetes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'GLP-1 receptor agonists and HBA1c target of'. Together they form a unique fingerprint.

Cite this